Gawlitta Debby, Benders Kim E M, Visser Jetze, van der Sar Anja S, Kempen Diederik H R, Theyse Lars F H, Malda Jos, Dhert Wouter J A
1 Department of Orthopedics, University Medical Center Utrecht , Utrecht, The Netherlands .
Tissue Eng Part A. 2015 Feb;21(3-4):694-703. doi: 10.1089/ten.TEA.2014.0117. Epub 2014 Nov 20.
Following an endochondral approach to bone regeneration, multipotent stromal cells (MSCs) can be cultured on a scaffold to create a cartilaginous callus that is subsequently remodeled into bone. An attractive scaffold material for cartilage regeneration that has recently regained attention is decellularized cartilage-derived matrix (CDM). Since this material has shown potential for cartilage regeneration, we hypothesized that CDM could be a potent material for endochondral bone regeneration. In addition, since decellularized matrices are known to harbor bioactive cues for tissue formation, we evaluated the need for seeded MSCs in CDM scaffolds. In this study, ectopic bone formation in rats was evaluated for CDM scaffolds seeded with human MSCs and compared with unseeded controls. The MSC-seeded samples were preconditioned in chondrogenic medium for 37 days. After 8 weeks of subcutaneous implantation, the extent of mineralization was significantly higher in the MSC-seeded constructs versus unseeded controls. The mineralized areas corresponded to bone formation with bone marrow cavities. In addition, rat-specific bone formation was confirmed by collagen type I immunohistochemistry. Finally, fluorochrome incorporation at 3 and 6 weeks revealed that the bone formation had an inwardly directed progression. Taken together, our results show that decellularized CDM is a promising biomaterial for endochondral bone regeneration when combined with MSCs at ectopic locations. Modification of current decellularization protocols may lead to enhanced functionality of CDM scaffolds, potentially offering the prospect of generation of cell-free off-the-shelf bone regenerative substitutes.
采用软骨内途径进行骨再生时,多能间充质干细胞(MSCs)可在支架上培养,以形成软骨痂,随后软骨痂再重塑为骨。一种最近重新受到关注的用于软骨再生的有吸引力的支架材料是脱细胞软骨衍生基质(CDM)。由于这种材料已显示出软骨再生的潜力,我们假设CDM可能是软骨内骨再生的有效材料。此外,由于已知脱细胞基质含有组织形成的生物活性线索,我们评估了CDM支架中接种MSCs的必要性。在本研究中,评估了接种人MSCs的CDM支架在大鼠体内的异位骨形成情况,并与未接种的对照组进行比较。接种MSCs的样本在软骨形成培养基中预处理37天。皮下植入8周后,接种MSCs的构建体中的矿化程度明显高于未接种的对照组。矿化区域对应于有骨髓腔的骨形成。此外,通过I型胶原免疫组织化学证实了大鼠特异性骨形成。最后,在第3周和第6周进行荧光染料掺入显示,骨形成具有向内的进展。综上所述,我们的结果表明,脱细胞CDM与MSCs在异位部位结合时,是软骨内骨再生的一种有前景的生物材料。对当前脱细胞方案的改进可能会导致CDM支架功能增强,有可能提供无细胞现成骨再生替代物的前景。